Li Zhilin
SEC CIK 1342188 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CPHI | CHINA PHARMA HOLDINGS, INC. | CEO, Interim CFO, Dir, 10% | 15.14M | — | — | 2 | 2021-09-09 | 2023-09-29 |
Most active insiders at CPHI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Li Zhilin made no open-market trades at CPHI in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-19 | 2023-09-29 | CPHI | CHINA PHARMA HOLDINGS, INC. | Li Zhilin | CEO, Interim CFO, Dir, 10% | A - Grant | $0.14 | +13.76M | 15.14M | +996% | +$1.93M | |
| 2021-09-13 | 2021-09-09 | CPHI | CHINA PHARMA HOLDINGS, INC. | Li Zhilin | CEO, Interim CFO, Dir, 10% | A - Grant | $0.67 | +1.76M | 13.81M | +15% | +$1.18M |
Purchase Sale Sale after option exercise All abbreviations